MktsMarkets

PACS Group, Inc.
NYSE: PACSKey statistics
PACS News
Stories mentioning PACS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 1,419,959 | 1,357,717 | 1,344,302 | 1,308,881 | 1,276,985 | 1,207,709 | 1,024,276 | 935,257 |
| Cost of Goods Sold | 849,599 | 762,147 | ||||||
| Gross Profit | 174,677 | 173,110 | ||||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 120,035 | 94,687 | 86,269 | 80,499 | 48,140 | 71,979 | 22,964 | (37,179) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 125.00 | 2,467 | 1,494 | (3,905) | ||||
| Pretax Income | 113,736 | 86,812 | 76,296 | 78,612 | 42,730 | 61,198 | 33,656 | (50,999) |
| Tax Provision | 33,068 | 27,027 | 23,966 | 27,646 | 14,350 | 25,007 | 17,446 | (19,123) |
| Net Income (Loss) | 80,695 | 59,702 | 52,406 | 50,963 | 28,472 | 37,201 | 15,620 | (31,878) |
| Earnings Per Share (Basic) | 0.51 | 0.38 | 0.33 | 0.33 | 0.18 | 0.25 | 0.10 | (0.21) |
| Earnings Per Share (Diluted) | 0.50 | 0.38 | 0.32 | 0.31 | 0.17 | 0.25 | 0.10 | (0.21) |
| Weighted Average Shares Outstanding (Basic) | 157,073 | 156,181 | 156,575 | 156,335 | 155,178 | 146,663 | 153,124 | 149,464 |
| Weighted Average Shares Outstanding (Diluted) | 162,080 | 156,700 | 164,709 | 165,474 | 166,416 | 148,575 | 158,453 | 149,464 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PACS
PACS Group, Inc. (NYSE: PACS) is a stock listed on the New York Stock Exchange under the ticker symbol PACS. It last traded at $48.92 (Oct 26, 2026, 1:50 PM ET), up 2.7% on the day. That gives PACS a market capitalisation of $7.5B and a price-to-earnings ratio of 28.0.
Over the past 52 weeks PACS has traded between $10.31 and $49.49.
Revenue for the quarter ended Mar 31, 2026 was $1.4B; net income $80.7M. Revenue was up 11.2% from $1.3B in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $1.4B | $80.7M | 5.7% |
| Dec 31, 2025 | $1.4B | $59.7M | 4.4% |
| Sep 30, 2025 | $1.3B | $52.4M | 3.9% |
| Jun 30, 2025 | $1.3B | $51.0M | 3.9% |
From PACS’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…